Cargando…
Surrogate end points and their role in clinical trials: Reply from authors
Autores principales: | Kalikar, M.V., Thawani, V.R., Varadpande, U.K., Sontakke, S.D., Singh, R.P., Khiyani, R.K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825019/ https://www.ncbi.nlm.nih.gov/pubmed/20177586 http://dx.doi.org/10.4103/0253-7613.48879 |
Ejemplares similares
-
Authors' reply
por: Kalikar, M.V., et al.
Publicado: (2010) -
Immunomodulatory effect of Tinospora cordifolia extract in human immuno-deficiency virus positive patients
por: Kalikar, M.V., et al.
Publicado: (2008) -
Surrogate end points and their role in clinical trial
por: Jaykaran,
Publicado: (2009) -
Authors' reply
por: Nair, Kavitha S., et al.
Publicado: (2009) -
Author's Reply
por: Godse, Kiran V.
Publicado: (2013)